|
KMID : 0378019900330040109
|
|
New Medical Journal
1990 Volume.33 No. 4 p.109 ~ p.112
|
|
|
Clinical Experience with Cefpimizole sodium
|
|
|
|
|
Abstract
|
|
|
Cefpimizole is recently developed semisynthetic cephalosporins that has a broad spectrum of bacteriostatic and bactericidal effects, especially against ß-lactamase producing bacteria.
Among 30 patients, 14 had respiratory tract infection, 8 sepsis, 6 urinary tract infection, 2 alimentary tract infection, and one CAPD infection. (One of these patients, had both respiratory tract infection and urinary tract infection). Total clinical efficiency was 83.3%, as for respiratory tract infection 84.6%, sepsis 87.5%, and urinary tract infection 83.3% separately.
Adverse effects were noted in 2 patients, with nausea and vomiting, which was well controlled with antiemetics.
|
|
|
KEYWORD
|
|
|
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|